Dr. Reddy's Laboratories Limited announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced sales was INR 43,838 million compared to INR 38,500 million a year ago. Operating loss was INR 5,869 million compared to operating Income of INR 5,729 million a year ago. Net loss was INR 5,697 million compared to net income of INR 4,852 million a year ago. Diluted loss per share was INR 34.37 compared to diluted earnings per share of INR 29.21 a year ago.